Categories
Africa GLOBE-NEWSWIRE MENA Pakistan Press Releases South Africa

VITAL VOICES HONORS WOMEN LEADING THE RISE AT 3RD ANNUAL FESTIVAL & 23RD ANNUAL GLOBAL LEADERSHIP AWARDS IN WASHINGTON, DC FROM MAY 29 to 30

Notable Speakers include Hillary Rodham Clinton, Diane von Furstenberg, Tarana Burke, Donna Langley, Amna Nawaz, Amber Tamblyn, and more; Vital Voices to Honor Nobel Laureate Maria Ressa, Marshall Islands President Hilda Heine, Diplomat Aya Chebbi, SafeCity Global, Activist Nika Kovač and Colombian Environmental Minister Susana Muhamad

WASHINGTON, D.C., May 28, 2024 (GLOBE NEWSWIRE) — Vital Voices Global Partnership (Vital Voices) is combining two of its most beloved annual events into one spectacular week of inspiration and action with the Vital Voices Festival and 23rd Global Leadership Awards, taking place on May 29 and 30 in Washington, DC. These events will bring together and honor world leaders, activists, actors, supporters and journalists from around the globe.

“With a record-breaking number of elections to be held in 2024, expanding global crises and a wave of authoritarian regimes threatening to pull us backwards, women around the world are rising to meet this moment in every region,” said Vital Voices President and CEO Alyse Nelson. “Vital Voices is proud to honor the women defending progress and leading powerful movements for human rights, peace and justice.”

Held on May 29 and 30 at the Vital Voices Global Headquarters for Women’s Leadership—the world’s first embassy for women—in Washington, DC, the festival serves as a homecoming for our network of women leaders, partners, and supporters from around the world. Festival speakers of note include Secretary Hillary Rodham Clinton, a Vital Voices co-founder, who will moderate a panel on women defending democracy, Entrepreneur and Vital Voices Board Member Diane von Furstenberg, Author, Actor and Director Amber Tamblyn, who will moderate a panel discussing the critical role of male allies in the fight for gender equality and combating gender-based violence, and more. CNN International Correspondent Jomana Karadsheh will speak on a panel exploring peacebuilding efforts amidst the Gaza-Israel conflict alongside Arwa Damon, founder and president of International Network for Aid, Relief & Assistance (INARA). The festival will also include Ambassador-at-Large for Global Women’s Issues at the U.S. Department of State Geeta Rao Gupta; Daughters for Earth Co-Founder Zainab Salbi; Co-Founder & CEO of The American Sunlight Project and Adjunct Professor, Syracuse University Nina Jankowicz; Feminist, Activist and Author of The Resilience Myth Soraya Chemaly; three-time NYT Bestselling Author Gayle Tzemach Lemmon, and many more.

The 23rd Annual Global Leadership Awards at The John F. Kennedy Center for the Performing Arts on May 30 will honor and pay tribute to five women and one organization whose leadership is helping move the world forward: Nobel Laureate and Rappler Co-founder and CEO Maria Ressa for her unwavering commitment to fight for press freedom in the Philippines, President of the Marshall Islands Hilda Heine for her work on the front lines of climate change, Diplomat and Feminist Aya Chebbi, whose blogging and voice for democracy rose to prominence during the Tunisian Revolution, Activist Nika Kovač for building coalitions to transform legal precedent on gender and economic inequalities in Slovenia, Minister of Environment and Sustainable Development of Colombia Susana Muhamad for her sustainability and environmental conservation work, and non-profit SafeCity Global. Secretary Clinton and Diane von Furstenberg will also present at the Global Leadership Awards.

The Vital Voices festival is open by invitation only. The Global Leadership Awards is open to members of the public who reserve a seat. Ticketing and more information about the Vital Voices Festival and Global Leadership Awards can be found at www.vitalvoices.org.

About Vital Voices Global Partnership
Now celebrating 27 years, Vital Voices Global Partnership has directly invested in more than 20,000 women leaders across 185 countries and territories since its inception in 1997. Driven by the universal truth that women are the key to progress in their communities and nations cannot move forward without women in leadership positions, Vital Voices has provided early support for leaders who went on to become Nobel Peace Prize Laureates, U.S. Youth Poet Laureates, prime ministers, award-winning innovators, pioneering human rights defenders, and breakthrough social entrepreneurs, including Amanda Gorman and Malala Yousafzai. In an effort to advance and expand this work, in 2022 Vital Voices opened the doors to the world’s first global embassy for women, the Vital Voices Global Headquarters for Women’s Leadership. It is a first-of-its-kind space that allows for convening, innovation, planning, and action—all in the pursuit of serving women leaders who are taking on the world’s greatest challenges.

Attachment

Emmanuelle Errera
Vital Voices
2024460513
EmmanuelleE@vitalvoices.org

GlobeNewswire Distribution ID 9144606

Categories
Africa GLOBE-NEWSWIRE MENA Pakistan Press Releases South Africa

Music Licensing, Inc. (OTC: SONGD) Acquires Prestigious Royalty-Generating IP Stake in “Goodnight Gotham” by Rihanna

NAPLES, Fla., May 28, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG) (OTC: SONGD), a distinguished leader in the acquisition and management of music royalties, proudly announces the acquisition of royalty-generating intellectual property in the chart-topping track “Goodnight Gotham” by Rihanna. This strategic acquisition enhances our portfolio with high-caliber assets from one of the industry’s most influential artists.

“Goodnight Gotham” is a testament to Rihanna’s enduring popularity and wide-reaching influence. This acquisition is set to provide consistent revenue streams across various platforms, including streaming services, radio, and media outlets.

Watch “Goodnight Gotham” by Rihanna here.

About Music Licensing, Inc. (OTC: SONG) (OTC: SONGD) (ProMusicRights.com)

Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, is a diversified holding company and the fifth public performance rights organization (PRO) formed in the United States. Its licensees include notable companies such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others. Pro Music Rights holds an estimated market share of 7.4% in the United States, representing over 2,500,000 works by notable artists such as A$AP Rocky, Wiz Khalifa, Pharrell, Young Jeezy, Juelz Santana, Lil Yachty, MoneyBagg Yo, Larry June, Trae Pound, Sauce Walka, Trae Tha Truth, Sosamann, Soulja Boy, Lex Luger, Trauma Tone, Lud Foe, SlowBucks, Gunplay, OG Maco, Rich The Kid, Fat Trel, Young Scooter, Nipsey Hussle, Famous Dex, Boosie Badazz, Shy Glizzy, 2 Chainz, Migos, Gucci Mane, Young Dolph, Trinidad James, Chingy, Lil Gnar, 3OhBlack, Curren$y, Fall Out Boy, Money Man, Dej Loaf, Lil Uzi Vert, and countless others, as well as artificial intelligence (A.I.) created music.

Additionally, Music Licensing, Inc. (OTC: SONG) owns royalty stakes in Listerine “Mouthwash” Antiseptic and musical works by artists such as The Weeknd, Justin Bieber, Kanye West, Elton John, Mike Posner, blackbear, Lil Nas X, Lil Yachty, DaBaby, Stunna 4 Vegas, Miley Cyrus, Lil Wayne, XXXTentacion, Jeremih, Ty Dolla $ign, Eric Bellinger, Ne-Yo, MoneyBagg Yo, Halsey, Desiigner, DaniLeigh, Rihanna, and numerous others.

Forward-Looking Statements:

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Music Licensing, Inc. & Pro Music Rights, Inc. to accomplish its stated plan of business. Music Licensing, Inc. & Pro Music Rights, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Pro Music Rights, Inc., Music Licensing, Inc., or any other person.

Non-Legal Advice Disclosure:

This press release does not constitute legal advice, and readers are advised to seek legal counsel for any legal matters or questions related to the content herein.

Non-Investment Advice Disclosure:

This communication is intended solely for informational purposes and does not in any way imply or constitute a recommendation or solicitation for the purchase or sale of any securities, commodities, bonds, options, derivatives, or any other investment products. Any decisions related to investments should be made after thorough research and consultation with a qualified financial advisor or professional. We assume no liability for any actions taken or not taken based on the information provided in this communication

Contact: investors@ProMusicRights.com

SOURCE: Music Licensing, Inc.

GlobeNewswire Distribution ID 9144217

Categories
Africa GLOBE-NEWSWIRE MENA Pakistan Press Releases South Africa

Duck Creek Technologies Recognizes IAT Insurance Group and Coforge with its Standard of Excellence Award

IAT Insurance Group, in strategic partnership with Coforge, takes home the Standard of Excellence Customer Award for the transition from multiple siloed legacy policy administration systems into the cloud-based Duck Creek system, driving digital transformation

BOSTON, May 28, 2024 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has recognized both IAT Insurance Group and their strategic transformation partner, Coforge, with the 2024 Standard of Excellence Customer Award winner at Formation ’24 in Dallas.

The Duck Creek Standard of Excellence Customer Awards recognizes customers who have achieved the highest level of excellence through their implementation of Duck Creek solutions and who are reimagining the future of insurance.

IAT Insurance Group, a leading specialty insurance company providing property, casualty, and surety products for niche markets, earned the Standard of Excellence Customer Award for the transformation of 7 diverse business segments that includes General Liability, Property, Management Liability, Excess, Inland Marine, and Commercial Auto lines of business. Moving key product lines onto the Duck Creek system has helped streamline the property and casualty insurer’s internal operations, improve user experience, and improve access to data and analytics.

Manish Chawla, CIO, IAT Insurance Group said, “We are honored to receive the Standard of Excellence Award. Our vision for transformation is deeply aligned with our business priorities and our commitment to serving our customers better. We believe in leveraging technology to create solutions that not only meet but exceed our customers’ expectations. This journey of transformation has been made possible through our strategic partnership with Coforge. Our shared vision has been instrumental in helping us turn our vision into reality, enabling us to deliver superior value to our customers.”

As part of a large, multi-year, multi-million-dollar business transformation initiative, IAT Insurance transitioned multiple lines of business onto the Duck Creek Full Suite, covering 50 states. This effort, supported by Coforge, was designed to modernize legacy systems, enhance scalability, and ensure regulatory compliance across IAT’s diverse portfolio of insurance products.

Rajeev Batra, Executive Vice President, Insurance, Coforge, said, “As a Premier Delivery Partner for Duck Creek Technologies, with 1000+ Duck Creek SME’s globally, Coforge is proud to be a part of IAT Insurance Group’s transformation journey. The synergy between Coforge, IAT Insurance Group and Duck Creek Technologies exemplifies flawless teamwork and collaboration.”

“It’s a great honor to be recognized with the Standard of Excellence Award. Our focus has been on leveraging innovative solutions to drive digital transformation for IAT Insurance Group. Our collaborative efforts have led to the successful transition of multiple business units onto a modern platform, enhancing scalability and regulatory compliance.”

About Duck Creek Technologies

Duck Creek Technologies is the intelligent solutions provider defining the future of the property and casualty (P&C) and general insurance industry. We are the platform upon which modern insurance systems are built, enabling the industry to capitalize on the power of the cloud to run agile, intelligent, and evergreen operations. Authenticity, purpose, and transparency are core to Duck Creek, and we believe insurance should be there for individuals and businesses when, where, and how they need it most. Our market-leading solutions are available on a standalone basis or as a full suite, and all are available via Duck Creek OnDemand. Visit www.duckcreek.com to learn more. Follow Duck Creek on our social channels for the latest information – LinkedIn and X.

Media Contacts:
Carley Bunch
carley.bunch@duckcreek.com

About IAT Insurance Group

IAT Insurance Group (IAT) is a privately owned, specialty insurance company providing property, casualty, and surety products for niche markets. IAT goes to market through eight business units – Commercial Transportation, Excess & Surplus, Homeowners, Programs, Inland Marine, Reinsurance, Surety and Management Liability. The IAT Insurance Group companies are rated A- Excellent by A.M. Best. Connect with IAT Insurance Group on LinkedIn and learn more about the company at iatinsurancegroup.com.

About Coforge

Coforge is a global digital services and solutions provider, which leverages emerging technologies and deep domain expertise to deliver real-world business impact for its clients. A focus on very selects industries, a detailed understanding of the underlying processes of those industries, and partnerships with leading platforms provide us with a distinct perspective. Coforge leads with its product engineering approach and leverages Cloud, Data, Integration, and Automation technologies to transform client businesses into intelligent, high-growth enterprises. Coforge’s proprietary platforms power critical business processes across its core verticals. The firm has a presence in 21 countries with 25 delivery centres across nine countries.

GlobeNewswire Distribution ID 9123545

Categories
GLOBE-NEWSWIRE MENA Pakistan Press Releases

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI

NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Class Period”), of the important July 12, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Inari Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Inari Medical class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period touted Inari’s “record revenue,” purportedly driven by “the strength in our core [venous thromboembolism] (“VTE”) business.” But defendants failed to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari’s products. In truth, while defendants were speaking positively about Inari Medical’s growth prospects, it had been engaging in illegal business practices. Specifically, Inari Medical had been unlawfully compensating health care professionals in violation of the federal Anti-Kickback Statute and Civil False Claims Act. Defendants also misled investors regarding business expenses in order to conceal their illicit conduct. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Inari Medical class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9123552

Categories
GLOBE-NEWSWIRE MENA Pakistan Press Releases

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – INTC

NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intel Corporation (NASDAQ: INTC) between January 25, 2024 and April 25, 2024, both dates inclusive (the “Class Period”), of the important July 2, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Intel securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Intel class action, go to https://rosenlegal.com/submit-form/?case_id=24741 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 2, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the growth of Intel Foundry Services (“IFS”) was not indicative of revenue growth reportable under the Internal Foundry segment; (2) the internal foundry model (“Foundry” model) experienced significant operating losses in 2023; (3) the Foundry experienced a decline in product profit driven by lower internal revenue; (4) as a result the Foundry model would not be a strong tailwind to Intel’s IFS strategy; and (5) as a result of the foregoing, defendants’ positive statements about Intel’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Intel class action, go to https://rosenlegal.com/submit-form/?case_id=24741 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9123584

Categories
GLOBE-NEWSWIRE MENA Pakistan Press Releases

LUNA DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Luna Innovations Incorporated Investors to Secure Counsel Before Important May 31 Deadline in Securities Class Action First Filed by the Firm – LUNA

NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Luna Innovations Incorporated (NASDAQ: LUNA) between August 11, 2023 and March 25, 2024, both dates inclusive (the “Class Period”), of the important May 31, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Luna Innovations securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Luna Innovations class action, go to https://rosenlegal.com/submit-form/?case_id=23678 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 31, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Luna Innovations’ financial statements from August 10, 2023 to the present included false figures as a result of improper revenue recognition; (2) as a result, Luna Innovations would need to restate its previously filed financial statements from August 10, 2023 to November 14, 2023; (3) Luna Innovations lacked adequate internal controls; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Luna Innovations class action, go to https://rosenlegal.com/submit-form/?case_id=23678 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9123491

Categories
GLOBE-NEWSWIRE MENA Pakistan Press Releases

BLUE FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action – BLUE

NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023, both dates inclusive (the “Class Period”), of the important May 28, 2024 lead plaintiff deadline.

SO WHAT: If you purchased bluebird common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the bluebird class action, go to https://rosenlegal.com/submit-form/?case_id=23717 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 28, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements. Specifically, defendants created the false impression that: (1) bluebird could obtain Federal Drug Administration (“FDA”) approval for lovo-cel, a gene therapy for sickle cell patients, without any black box warnings for haematological malignancies; (2) bluebird would be granted a priority review voucher by the FDA and in turn sell it in order to strengthen bluebird’s financial position for the lovo-cel launch; (3) as a result, bluebird had significantly overstated Lyfgenia’s clinical and/or commercial prospects; and (4) therefore, bluebird’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the bluebird class action, go to https://rosenlegal.com/submit-form/?case_id=23717 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9123502

Categories
GLOBE-NEWSWIRE MENA Pakistan Press Releases

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Li Auto Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action with an Expanded Class Period – LI

NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Li Auto Inc. (NASDAQ: LI) between February 26, 2024 and March 20, 2024, both dates inclusive (the “Class Period”), of the important July 9, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Li Auto securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Li Auto class action, go to https://rosenlegal.com/submit-form/?case_id=11199 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 9, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Li Auto had overstated the demand for its vehicles and the efficacy of its operating strategy in launching the Li MEGA, Li Auto’s first battery electric vehicle model; (2) accordingly, Li Auto was unlikely to meet its Q1 2024 vehicle deliveries estimate; (3) the foregoing, once revealed, was likely to have a material negative impact on Li Auto’s financial condition; and (4) as a result, Li Auto’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Li Auto class action, go to https://rosenlegal.com/submit-form/?case_id=11199 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9123548

Categories
Africa GLOBE-NEWSWIRE MENA Pakistan Press Releases South Africa

Duck Creek Technologies Celebrates Innovation Champions expert.ai and Cognizant at Formation ’24 Hatch-a-Thon

From 40 entrants, solution partner finalists expert.ai, Glia, and Milliman, and systems integrator finalists Cognizant, Coforge, and Capgemini showed their innovative solutions aimed at simplifying the insurance industry

BOSTON, May 23, 2024 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, proudly announces the winners of its annual Hatch-a-Thon at Formation ’24. Out of numerous entrants, solution partner expert.ai and systems integrator Cognizant emerged as the champions, showcasing their groundbreaking solutions dedicated to simplifying the insurance industry.

Duck Creek Technologies witnessed an impressive array of entries in its third year of inviting external ecosystem participants and conference attendees to the Hatch-a-Thon. The event brought together its internal teams and developer community to hatch new ideas to further simplify the complexity and foster innovation within the insurance industry. It encouraged ecosystem partners to present ideas focused on maintaining the human touch in the industry, exploring synergy within insurance operations, and integrating technologies for an enhanced customer experience.

The Hatch-a-Thon marathon garnered a substantial 40 entries, each evaluated closely by Duck Creek’s Innovation Anywhere committee. Entries were evaluated based on criteria such as innovation, product impact, business impact, and execution. Three outstanding solution partner finalists, expert.ai, Glia, and Milliman, and three commendable systems integrator finalists, Capgemini, Coforge, and Cognizant, were selected to showcase their ideas on the Formation ’24 stage, where attendees had the opportunity to witness the presentations of the finalists and cast their votes for the most innovative solution.

The ultimate champions of the Formation ’24 Hatch-a-Thon were decided, with expert.ai from the solution partner category and Cognizant from the systems integrator category emerging as the winners. This year’s winning solution partner team from expert.ai presented their groundbreaking solution, Medical Treatment Compliance with Q&A claims, which helps teams enhance treatment for injured patients and reduce insurers’ costs by flagging non-compliant provider plans against guidelines, while the victorious systems integrator team from Cognizant showcased their impressive creation, Nextgen Claim Assistant, which empowers loss adjusters to generate contextual responses with meaningful insights to accelerate decisions and quick claim settlement.

“Duck Creek’s unwavering commitment to propelling advancements and simplifying complexity in the global property and casualty and general insurance industry is reflected in its dedication to fostering innovation and collaboration,” said Luis Amadeo, SVP Product Strategy & Innovation at Duck Creek Technologies. “Through events like the Hatch-a-Thon and our robust partner ecosystem, Duck Creek is able to drive novel advancements for our customers.”

About Duck Creek Technologies

Duck Creek Technologies is the intelligent solutions provider defining the future of the property and casualty (P&C) and general insurance industry. We are the platform upon which modern insurance systems are built, enabling the industry to capitalize on the power of the cloud to run agile, intelligent, and evergreen operations. Authenticity, purpose, and transparency are core to Duck Creek, and we believe insurance should be there for individuals and businesses when, where, and how they need it most. Our market-leading solutions are available on a standalone basis or as a full suite, and all are available via Duck Creek OnDemand. Visit www.duckcreek.com to learn more. Follow Duck Creek on our social channels for the latest information – LinkedIn and X.

Media Contacts:
Carley Bunch
carley.bunch@duckcreek.com

GlobeNewswire Distribution ID 9122978

Categories
GLOBE-NEWSWIRE MENA Pakistan Press Releases

Nyxoah Announces Pricing of Offering

REGULATED INFORMATION
INSIDE INFORMATION

Nyxoah Announces Pricing of Offering

Mont-Saint-Guibert, Belgium – May 23, 2024, 3:50 pm CET / 9:50 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the pricing of an underwritten public offering in the United States, which includes shares sold in a private offering to certain qualified or institutional investors outside the United States, including within the European Union, of 5,374,755 of its ordinary shares at an offering price of $9.25 (EUR 8.54) per share, before underwriting discounts and commissions. All of the ordinary shares are being offered by Nyxoah and there are no selling stockholders participating in the offering. In addition, Nyxoah has granted the underwriters a 30-day option to purchase up to an additional 806,213 ordinary shares at the offering price, before underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Nyxoah, are expected to be approximately $50 million (EUR 46.2 million), excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close May 28, 2024, subject to the satisfaction of customary closing conditions.

Nyxoah intends to use the net proceeds from the proposed offering (i) for pre-commercialization and commercialization activities in the United States; (ii) to continue gathering clinical data and to support physician initiated clinical research projects related to OSA patient treatments; (iii) to further finance research and development activities related to the next generation of the Genio system and to continue to build a pipeline of new technologies and explore potential collaboration opportunities in the field of monitoring and diagnostics for OSA; and (iv) for other general corporate purposes, including, but not limited to, working capital, capital expenditures, investments, acquisitions, should the Company choose to pursue any, and collaborations.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. Degroof Petercam is acting as a co-manager.

The public offering in the United States is being made pursuant to an effective shelf registration statement on Form F-3 (File No. 333-268955) that was filed by Nyxoah with the U.S. Securities and Exchange Commission (the “SEC”) and became effective on January 6, 2023. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering, when available, may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the final prospectus supplement and the accompanying prospectus relating to the offering, when available, may be obtained by contacting: Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022; email: prospectus@cantor.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Additional information
The following information is provided pursuant to Article 7:97 of the Belgian Companies and Associations Code. Prior to the launch of the offering, Robert Taub, who is the chairman of the board of directors, had expressed an interest to participate in the offering and purchase (either directly or indirectly through entities controlled/managed by him or otherwise) offered shares, it being understood that the number of offered shares allocated to Robert Taub (if any) and the applicable price would depend on the outcome of the offering process.

As Robert Taub qualifies as a related party of the Company, the board of directors applied the related parties procedure of Article 7:97 of the Belgian Companies and Associations Code in connection with the potential participation of Robert Taub (either directly or indirectly through entities controlled/managed by him or otherwise) to the offering. Within the context of the aforementioned procedure, prior to resolving on the offering, a committee of three independent directors of the Company (the “Committee”) issued an advice to the board of directors in which the Committee assessed the participation of Robert Taub in the offering. In its advice to the board of directors, the Committee concluded the following: “Based on the information provided, the Committee considers that the proposed transaction is in line with the strategy pursued by the Company, will be done on market terms, and is unlikely to lead to disadvantages for the Company and its shareholders (in terms of dilution) that are not sufficiently compensated by the advantages that the transaction offers the Company”.

When approving the offering, the Company’s board of directors did not deviate from the Committee’s advice. The Company’s statutory auditor’s assessment of the Committee’s advice and the minutes of the meeting of the Company’s board of directors, is as follows: “Based on our limited review performed in accordance with ISRE 2410 “ Review of interim financial information performed by the independent auditor of the entity” and the applicable standards of the “Institut des Réviseurs d’Entreprises/Instituut der Bedrijfsrevisoren”, nothing has come to our attention that causes us to believe that the financial and accounting data contained in the minutes of the board of directors’ meeting of May 22, 2024 and in the advice of the committee of independent directors in accordance with article 7:97 of the Companies and Associations Code would contain material inconsistencies with the information available to us in the course of our engagement. However, we do not express an opinion on the value of the transaction or on the appropriateness of the decision of the board of directors”.

Important Information
No public offering will be made and no one has taken any action that would, or is intended to, permit a public offering in any country or jurisdiction, other than the United States, where any such action is required, including in Belgium. Belgian investors, other than qualified investors within the meaning of the Belgian Act of 11 July 2018 on the public offering of securities and the admission of securities to be traded on a regulated market, will not be eligible to participate in the offering (whether in Belgium or elsewhere). The transaction to which this press release relates will only be available to, and will be engaged in only with, in member states of the European Economic Area, (i) any person who is a “qualified investor” as defined in Regulation (EU) 2017/1129 (the “EU Prospectus Regulation”), or (ii) fewer than 150 natural or legal persons, per each member state of the European Economic Area, other than “qualified investors” (as defined in the EU Prospectus Regulation) who acquire ordinary shares for a total consideration of at least €100,000 per investor.

In the United Kingdom, the transaction to which this press release relates will only be available to, and will only be engaged in with, persons who are “qualified investors” (as defined in the UK Prospectus Regulation being the UK version of Regulation (EU) No 2017/1129 as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.) who also (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), and/or (ii) are “high net worth companies” (or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2) (a) to (d) of the Order (any such person being referred to as a “Relevant Person”). Any person who is not a Relevant Person should not take any action on the basis of this announcement and should not act or rely on it.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-Looking Statements

This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements may be identified by words such as “expects,” “potential,” “could,” or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements include express or implied statements relating to, among other things, Nyxoah’s current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies; and statements relating to the offering, including the expected closing, the anticipated proceeds from the offering and the use thereof. These statements are neither promises nor guarantees and are subject to a variety of risks and uncertainties, many of which are beyond Nyxoah’s control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, these risks and uncertainties include, without limitation, risks relating to market conditions and the Company’s inability, or the inability of the underwriters, to satisfy the conditions for the closing of the offering. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. Other risks and uncertainties faced by Nyxoah include those identified under the heading “Risk Factors” in Nyxoah’s most recent Annual Report on Form 20-F filed with the SEC, as well as subsequent filings and reports filed with the SEC. The forward-looking statements contained in this press release reflect Nyxoah’s views as of the date hereof, and Nyxoah does not assume and specifically disclaims any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
IR@nyxoah.com

Attachment

GlobeNewswire Distribution ID 1000952500